TY  - GEN
AU  - Joerger,M
AU  - Matter-Walstra,K
AU  - Früh,M
AU  - Kühnel,U
AU  - Szucs,T
AU  - Pestalozzi,B
AU  - Schwenkglenks,M
TI  - Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis
SN  - 1569-8041
PY  - 2011///0614
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - economics
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cetuximab
KW  - Cisplatin
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Lung Neoplasms
KW  - Markov Chains
KW  - Monte Carlo Method
KW  - Neoplasm Staging
KW  - Proportional Hazards Models
KW  - Sensitivity and Specificity
KW  - Survival Analysis
KW  - Treatment Failure
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdq431
ER  -